"Hospital Ruber Internacional, líder en el sector de la sanidad privada, es una referencia por su calidad, por su tecnología de última generación, por sus profesionales altamente cualificados y por su vocación permanente de superación."

During the past decade, Hospital Ruber Internacional conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 6 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 5 clinical trials were completed. i.e. 26.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Ruber Internacional" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "MacroGenics" with 3 trials sponsored, "MedSIR" with 3 trials sponsored, "Spanish Breast Cancer Research Group" with 3 trials sponsored and "GlaxoSmithKline" with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Ruber Internacional" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 2 trials as a collaborator, "AB Biotek" with 1 trials as a collaborator, "Anavex Germany GmbH" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Ruber Internacional" are "Breast Cancer" (9 trials), "Epilepsy" (4 trials), "Metastatic Breast Cancer" (4 trials), "Dravet Syndrome" (2 trials) and "Non Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Hospital Ruber Internacional" in a lesser frequency.

Most popular intervention types in "Hospital Ruber Internacional" are "Drug" (32 trials), "Biological" (5 trials), "Other" (4 trials), "Diagnostic Test" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Exemestane" (4 trials), "Placebo" (4 trials), "Fulvestrant" (3 trials), "Abemaciclib" (2 trials) and "Alpelisib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Ruber Internacional" are 35 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Ruber Internacional". undefined are not yet recruiting, 9 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Hospital Ruber Internacional, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Ruber Internacional, 4 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".

Hospital Ruber Internacional has several departments that took part in Clinical trials: "Hospital Ruber Internacional, Servicio de neurología" - 7 trials, "Hospital Ruber Internacional;Servicio de Oncologia" - 4 trials, "Hospital Ruber Internacional Primera Planta Servicio de Neurologia" - 2 trials